NVO
Price
$56.14
Change
-$0.60 (-1.06%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
252.56B
62 days until earnings call
TECH
Price
$52.88
Change
-$0.46 (-0.86%)
Updated
Sep 4, 02:42 PM (EDT)
Capitalization
8.3B
61 days until earnings call
Interact to see
Advertisement

NVO vs TECH

Header iconNVO vs TECH Comparison
Open Charts NVO vs TECHBanner chart's image
Novo-Nordisk A/S
Price$56.14
Change-$0.60 (-1.06%)
Volume$34.18K
Capitalization252.56B
Bio-Techne
Price$52.88
Change-$0.46 (-0.86%)
Volume$600
Capitalization8.3B
NVO vs TECH Comparison Chart in %
Loading...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NVO vs. TECH commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NVO is a Buy and TECH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NVO: $56.74 vs. TECH: $53.34)
Brand notoriety: NVO and TECH are both not notable
NVO represents the Pharmaceuticals: Major, while TECH is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: NVO: 51% vs. TECH: 111%
Market capitalization -- NVO: $252.56B vs. TECH: $8.3B
NVO [@Pharmaceuticals: Major] is valued at $252.56B. TECH’s [@Biotechnology] market capitalization is $8.3B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $661.43B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.22B. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NVO’s FA Score shows that 2 FA rating(s) are green whileTECH’s FA Score has 2 green FA rating(s).

  • NVO’s FA Score: 2 green, 3 red.
  • TECH’s FA Score: 2 green, 3 red.
According to our system of comparison, both NVO and TECH are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NVO’s TA Score shows that 4 TA indicator(s) are bullish while TECH’s TA Score has 4 bullish TA indicator(s).

  • NVO’s TA Score: 4 bullish, 3 bearish.
  • TECH’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NVO is a better buy in the short-term than TECH.

Price Growth

NVO (@Pharmaceuticals: Major) experienced а +0.53% price change this week, while TECH (@Biotechnology) price change was -5.12% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.37%. For the same industry, the average monthly price growth was +1.83%, and the average quarterly price growth was +9.29%.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.27%. For the same industry, the average monthly price growth was +7.08%, and the average quarterly price growth was +29.28%.

Reported Earning Dates

NVO is expected to report earnings on Nov 05, 2025.

TECH is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.37% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+0.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($253B) has a higher market cap than TECH($8.3B). TECH has higher P/E ratio than NVO: TECH (115.96) vs NVO (14.49). TECH YTD gains are higher at: -25.627 vs. NVO (-32.220).
NVOTECHNVO / TECH
Capitalization253B8.3B3,049%
EBITDAN/AN/A-
Gain YTD-32.220-25.627126%
P/E Ratio14.49115.9612%
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A423M-
FUNDAMENTALS RATINGS
NVO vs TECH: Fundamental Ratings
NVO
TECH
OUTLOOK RATING
1..100
1852
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
4
Undervalued
PROFIT vs RISK RATING
1..100
77100
SMR RATING
1..100
1580
PRICE GROWTH RATING
1..100
6462
P/E GROWTH RATING
1..100
9812
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECH's Valuation (4) in the Biotechnology industry is in the same range as NVO (16) in the Pharmaceuticals Major industry. This means that TECH’s stock grew similarly to NVO’s over the last 12 months.

NVO's Profit vs Risk Rating (77) in the Pharmaceuticals Major industry is in the same range as TECH (100) in the Biotechnology industry. This means that NVO’s stock grew similarly to TECH’s over the last 12 months.

NVO's SMR Rating (15) in the Pharmaceuticals Major industry is somewhat better than the same rating for TECH (80) in the Biotechnology industry. This means that NVO’s stock grew somewhat faster than TECH’s over the last 12 months.

TECH's Price Growth Rating (62) in the Biotechnology industry is in the same range as NVO (64) in the Pharmaceuticals Major industry. This means that TECH’s stock grew similarly to NVO’s over the last 12 months.

TECH's P/E Growth Rating (12) in the Biotechnology industry is significantly better than the same rating for NVO (98) in the Pharmaceuticals Major industry. This means that TECH’s stock grew significantly faster than NVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NVOTECH
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
60%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
68%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
69%
Advances
ODDS (%)
Bullish Trend 14 days ago
67%
Bullish Trend 23 days ago
72%
Declines
ODDS (%)
Bearish Trend 10 days ago
59%
Bearish Trend 2 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
43%
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TECH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IHRT2.310.07
+3.12%
iHeartMedia
NBHC39.030.02
+0.05%
NATIONAL BANK HOLDINGS Corp
R186.05-0.82
-0.44%
Ryder System
SLNHP2.45-0.07
-2.78%
Soluna Holdings
SCWO0.33-0.01
-3.98%
374Water

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with ADAP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then ADAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+0.64%
ADAP - NVO
38%
Loosely correlated
-9.00%
GMAB - NVO
35%
Loosely correlated
+4.60%
TECH - NVO
35%
Loosely correlated
-0.15%
BCAB - NVO
35%
Loosely correlated
+9.06%
MRK - NVO
34%
Loosely correlated
-1.52%
More

TECH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECH has been loosely correlated with SYRE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TECH jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECH
1D Price
Change %
TECH100%
-0.15%
SYRE - TECH
47%
Loosely correlated
+1.08%
MRVI - TECH
46%
Loosely correlated
-0.42%
MRNA - TECH
45%
Loosely correlated
-0.58%
CDXS - TECH
45%
Loosely correlated
-3.98%
FTRE - TECH
44%
Loosely correlated
+6.79%
More